LQDA Q3 2025 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$54M+1121.7% YoY

Gross Profit

$51M94.2% margin

Operating Income

$2M3.3% margin

Net Income

-$4M-6.5% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+514.9%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$276M

Total Liabilities

$254M

Stockholders' Equity

$22M

Cash & Equivalents

$157M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$4M	+1121.7%
Gross Profit	$51M	$3M	+1674.9%
Operating Income	$2M	-$29M	+106.1%
Net Income	-$4M	-$23M	+84.7%

Revenue Segments

Product

$52M95%

Service

$3M5%